LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0312417 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Li-Qiang Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Traditional Chinese Medicine Oncology Center, Shenzhen, Guangdong, P. R. China. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, Wnt Signaling Pathway, Wnt Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sanming Project of Medicine in Shenzen Municipality.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a prevalent form of malignant tumor, and the current clinical treatments are far from satisfactory. Identifying new therapeutic targets is therefore essential for clinical practices. The long intergenic non-protein coding RNA lincROR has been shown to play a significant role in the tumorigenesis of various cancers. However, the molecular mechanism underlying lincROR-mediated CRC tumorigenesis remains unclear. In the present study, we found that knockdown of lincROR significantly inhibited cell viability in vitro , while its overexpression promoted tumor growth in vivo . Mechanistically, lincROR acted as a miRNA sponge for miR-145, thereby elevating the expression of the target genes WNT2B and WNT10A. The overexpression of WNT2B and WNT10A definitely activated the Wnt/β-catenin pathway, thus led to promoting tumorigenesis in CRC. In summary, our findings identified lincROR as a novel activator of the Wnt/β-catenin pathway by serving as a miRNA sponge for miR-145 and facilitating tumorigenesis, which suggests that lincROR may be a potential therapeutic target for CRC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shenzhen Traditional Chinese Medicine Oncology Center, Shenzhen, Guangdong, P. R. China.
- Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, P. R. China.
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, P. R. China.
ORCID-Profile: Zhang Jin-Fang
Förderung
- National Natural Science Foundation of China
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Deng, L. Q., Li, S. Y., Xie, T., Zeng, W. Q., Wang, Y. Y., Shi, C. J., & Jin-Fang, Z. (2024). LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis. PLOS ONE. https://doi.org/10.1371/journal.pone.0312417
Vancouver
Deng LQ, Li SY, Xie T, Zeng WQ, Wang YY, Shi CJ, et al. LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis. PLOS ONE. 2024. doi:10.1371/journal.pone.0312417
BibTeX
@article{Deng2024,
author = {Deng, Li-Qiang and Li, Shi-Ying and Xie, Tian and Zeng, Wei-Qiang and Wang, Yu-Yan and Shi, Chuan-Jian and Jin-Fang, Zhang},
title = {LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0312417}
}
EUVIMED